Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 4,610,000 shares, an increase of 21.6% from the August 15th total of 3,790,000 shares. Currently, 5.6% of the shares of the stock are sold short. Based on an average daily volume of 708,900 shares, the days-to-cover ratio is currently 6.5 days.
Pediatrix Medical Group Stock Performance
Shares of NYSE MD traded up $0.41 during midday trading on Monday, hitting $17.99. 783,025 shares of the company's stock traded hands, compared to its average volume of 617,947. Pediatrix Medical Group has a 1 year low of $16.33 and a 1 year high of $29.48. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 17.94, a price-to-earnings-growth ratio of 1.14 and a beta of 1.88. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.39 and a current ratio of 1.39. The firm has a fifty day moving average of $20.42 and a 200 day moving average of $20.95.
Get
Pediatrix Medical Group alerts:
Pediatrix Medical Group (NYSE:MD – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.43 by $0.04. The firm had revenue of $486.00 million during the quarter, compared to analyst estimates of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 EPS. On average, analysts forecast that Pediatrix Medical Group will post 1.71 earnings per share for the current year.
Institutional Investors Weigh In On Pediatrix Medical Group
A number of institutional investors have recently added to or reduced their stakes in the stock. Captrust Financial Advisors grew its holdings in Pediatrix Medical Group by 100.4% during the 2nd quarter. Captrust Financial Advisors now owns 8,020 shares of the company's stock valued at $169,000 after buying an additional 4,019 shares in the last quarter. Eagle Bay Advisors LLC grew its holdings in Pediatrix Medical Group by 122.5% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company's stock valued at $34,000 after buying an additional 878 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Pediatrix Medical Group by 15.4% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 87,300 shares of the company's stock valued at $1,834,000 after acquiring an additional 11,651 shares during the last quarter. American International Group Inc. boosted its position in shares of Pediatrix Medical Group by 5.1% during the 2nd quarter. American International Group Inc. now owns 46,571 shares of the company's stock valued at $978,000 after acquiring an additional 2,260 shares during the last quarter. Finally, Comerica Bank boosted its position in shares of Pediatrix Medical Group by 11.6% during the 2nd quarter. Comerica Bank now owns 128,364 shares of the company's stock valued at $3,035,000 after acquiring an additional 13,292 shares during the last quarter. 95.98% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research analysts recently commented on MD shares. Credit Suisse Group decreased their target price on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Thursday, August 11th. BMO Capital Markets decreased their target price on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a research note on Wednesday, August 10th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $24.67.
Pediatrix Medical Group Company Profile
(Get Rating)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
- Upwork Shares Stumble into Bargain Territory
- Kroger's is Your One-Stop Consumer Staples Stock
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
